alexa Cachexia|omics Group|Journal Of Obesity And Weight Loss Therapy

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Cachexia-innovations.php

Cachexia is defined as an extreme wasting condition with marked weight loss, anorexia, and lassitude. About half of all cancer patients show a syndrome of cachexia characterized by loss of adipose tissue and skeletal muscle mass. Such patients have a decreased survival time compared with that of patients without weight loss. Abnormal metabolism is thought to be the basis of the cachexia status in advanced cancer patients. Cachexia induces the cytokines, in particular tumor necrosis factor (TNF)-α, IL-1, and IL-6, is thought to inhibit the activity of lipoprotein lipase (LPL), and thereby induces weight loss as a result of reduced fat accumulation in the tissues. Therefore, it is thought that emaciation of cancer patients might be prevented and cachexia improved by increasing LPL activity Innovations are new idea, device or process. Innovations are the application of better solutions that meet new requirements, inarticulated needs or existing market needs. It is proficient through more effective products, processes, services, technologies, or new ideas that are readily available to markets, governments and society. Innovations are something original and novel, as a significant, new that “breaks into” the market or society
 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords